Cart
0
 
 

World Drug Discovery Technologies Market - Opportunities and Forecasts, 2014 -2022

Get 20% Free Customization In This Report
Healthcare
LI_181480
Pages: NA
Mar 2019 | 1261 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

Drug discovery is the process by which new medications are discovered. It uses vast array of technologies in the process. Drug discovery technologies are used for the research and the launch of new drugs. Increased use of therapeutics in various diseases has created the need for drug discovery. Recently, with the development of technology, many new types of techniques such as nanotechnology and RNA interference are being used for the purpose of drug discovery. This has created the opportunities for drug discovery technology manufacturers in the new segments. The increasing incidences of diseases, patent expiries, pathogen resistance to old drugs and fierce competition among drug manufacturers are the key factors, which would drive the growth of drug discovery technologies market during the analysis period. Furthermore, in order to earn additional margins, the pharmaceutical companies are in pursuit of blockbuster drugs, which has increased the demand for drug discovery technologies. Factors restraining the market growth are long duration of drug discovery process, high initial setup cost and presence of stringent regulatory environment.

The global drug discovery market is segmented on the basis of technology type, application and geography. The technology types considered in this report are high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAi, combinatorial chemistry). Based on end user, the global drug discovery market is classified into pharmaceutical companies, biopharmaceutical companies, biotech companies and research institutes. Geographically, the report is segmented into four regions viz., North America, Europe, Asia-Pacific and LAMEA. One of the strategies adopted by major market players is collaboration. For instance, in 2015, Myriad Genetics collaborated with Abbott Laboratories. The companies profiled in this report are Abbott Laboratories, Albany Molecular Research, Arqule, Bio-Rad Laboratories, Caliper Life Sciences, Celera Corp, Charles River Laboratories International, Evotec Ag, Gyros AbIncyte Corp and Thermo Fisher Scientific Inc.

KEY MARKET BENEFITS:

  • The report provides a quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • Extensive analysis of the global apheresis equipment market by product type helps in understanding the types of equipment that are currently used along with the variants that would gain prominence in future
  • Competitive intelligence highlights the business practices followed by leading market players across various geographies
  • Comprehensive analysis of factors that drive and restrict the growth of the global apheresis equipment market is provided
  • SWOT analysis highlights the internal environment of leading companies for effective strategy formulation
  • The apheresis equipment market scenario is comprehensively analysed in accordance to the key regions

KEY MARKET SEGMENTS:

The global drug discovery technologies market is segmented as below:

Global Drug Discovery Technologies Market By Technology Type

  • High throughput screening
  • Genomics
  • Biochips
  • Pharmacogenomics
  • Bioanalytical instruments
  • Bioinformatics
  • Nanotechnology
  • Others (RNAi, combinatorial chemistry)

Global Drug Discovery Technologies Market By End User

  • Pharmaceutical companies
  • Biopharmaceutical companies
  • Biotech companies
  • Research institutes

Global Drug Discovery Technologies Market By Geography

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. CURRENT DISRUPTIVE TECHNOLOGIES

Chapter: 4 DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HIGH THROUGHPUT SCREENING (HTS)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. GENOMICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. BIOCHIPS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. BIOANALYTICAL INSTRUMENTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. BIOINFORMATICS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. PROTEOMICS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.8. NANOTECHNOLOGY
4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.9. OTHER TECHNOLOGIES
4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast

Chapter: 5 DRUG DISCOVERY TECHNOLOGIES, BY APPLICATION

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CANCER
5.2.1. Market size and forecast
5.3. CARDIOVASCULAR DISEASES
5.3.1. Market size and forecast
5.4. CENTRAL NERVOUS SYSTEM DISORDERS
5.4.1. Market size and forecast
5.5. OTHER APPLICATIONS
5.5.1. Market size and forecast

Chapter: 6 DRUG DISCOVERY TECHNOLOGIES, BY END USER

6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. PHARMACEUTICAL COMPANIES
6.2.1. Market size and forecast
6.3. BIOPHARMACEUTICAL COMPANIES
6.3.1. Market size and forecast
6.4. BIOTECH COMPANIES
6.4.1. Market size and forecast
6.5. RESEARCH INSTITUTES
6.5.1. Market size and forecast
6.6. OTHER END USER
6.6.1. Market size and forecast

Chapter: 7 DRUG DISCOVERY TECHNOLOGIES, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. North America Drug Discovery Technologies Market, by Country
7.2.3.1. Market size and forecast
7.2.3.2. U.S.
7.2.3.2.1. U.S. Drug Discovery Technologies Market, by Technology
7.2.3.2.2. U.S. Drug Discovery Technologies Market, by Application
7.2.3.2.3. U.S. Drug Discovery Technologies Market, by End User
7.2.3.3. Canada
7.2.3.3.1. Canada Drug Discovery Technologies Market, by Technology
7.2.3.3.2. Canada Drug Discovery Technologies Market, by Application
7.2.3.3.3. Canada Drug Discovery Technologies Market, by End User
7.2.3.4. Mexico
7.2.3.4.1. Mexico Drug Discovery Technologies Market, by Technology
7.2.3.4.2. Mexico Drug Discovery Technologies Market, by Application
7.2.3.4.3. Mexico Drug Discovery Technologies Market, by End User
7.2.4. North America Drug Discovery Technologies Market, by Technology
7.2.5. North America Drug Discovery Technologies Market, by Application
7.2.6. North America Drug Discovery Technologies Market, by End User
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Europe Drug Discovery Technologies Market, by Country
7.3.3.1. Market size and forecast
7.3.3.2. Germany
7.3.3.2.1. Germany Drug Discovery Technologies Market, by Technology
7.3.3.2.2. Germany Drug Discovery Technologies Market, by Application
7.3.3.2.3. Germany Drug Discovery Technologies Market, by End User
7.3.3.3. France
7.3.3.3.1. France Drug Discovery Technologies Market, by Technology
7.3.3.3.2. France Drug Discovery Technologies Market, by Application
7.3.3.3.3. France Drug Discovery Technologies Market, by End User
7.3.3.4. UK
7.3.3.4.1. UK Drug Discovery Technologies Market, by Technology
7.3.3.4.2. UK Drug Discovery Technologies Market, by Application
7.3.3.4.3. UK Drug Discovery Technologies Market, by End User
7.3.3.5. Italy
7.3.3.5.1. Italy Drug Discovery Technologies Market, by Technology
7.3.3.5.2. Italy Drug Discovery Technologies Market, by Application
7.3.3.5.3. Italy Drug Discovery Technologies Market, by End User
7.3.3.6. Spain
7.3.3.6.1. Spain Drug Discovery Technologies Market, by Technology
7.3.3.6.2. Spain Drug Discovery Technologies Market, by Application
7.3.3.6.3. Spain Drug Discovery Technologies Market, by End User
7.3.3.7. Rest of Europe
7.3.3.7.1. Rest of Europe Drug Discovery Technologies Market, by Technology
7.3.3.7.2. Rest of Europe Drug Discovery Technologies Market, by Application
7.3.3.7.3. Rest of Europe Drug Discovery Technologies Market, by End User
7.3.4. Europe Drug Discovery Technologies Market, by Technology
7.3.5. Europe Drug Discovery Technologies Market, by Application
7.3.6. Europe Drug Discovery Technologies Market, by End User
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Asia-Pacific Drug Discovery Technologies Market, by Country
7.4.3.1. Market size and forecast
7.4.3.2. Japan
7.4.3.2.1. Japan Drug Discovery Technologies Market, by Technology
7.4.3.2.2. Japan Drug Discovery Technologies Market, by Application
7.4.3.2.3. Japan Drug Discovery Technologies Market, by End User
7.4.3.3. China
7.4.3.3.1. China Drug Discovery Technologies Market, by Technology
7.4.3.3.2. China Drug Discovery Technologies Market, by Application
7.4.3.3.3. China Drug Discovery Technologies Market, by End User
7.4.3.4. Australia
7.4.3.4.1. Australia Drug Discovery Technologies Market, by Technology
7.4.3.4.2. Australia Drug Discovery Technologies Market, by Application
7.4.3.4.3. Australia Drug Discovery Technologies Market, by End User
7.4.3.5. India
7.4.3.5.1. India Drug Discovery Technologies Market, by Technology
7.4.3.5.2. India Drug Discovery Technologies Market, by Application
7.4.3.5.3. India Drug Discovery Technologies Market, by End User
7.4.3.6. South Korea
7.4.3.6.1. South Korea Drug Discovery Technologies Market, by Technology
7.4.3.6.2. South Korea Drug Discovery Technologies Market, by Application
7.4.3.6.3. South Korea Drug Discovery Technologies Market, by End User
7.4.3.7. Rest of Asia-Pacific
7.4.3.7.1. Rest of Asia-Pacific Drug Discovery Technologies Market, by Technology
7.4.3.7.2. Rest of Asia-Pacific Drug Discovery Technologies Market, by Application
7.4.3.7.3. Rest of Asia-Pacific Drug Discovery Technologies Market, by End User
7.4.4. Asia-Pacific Drug Discovery Technologies Market, by Technology
7.4.5. Asia-Pacific Drug Discovery Technologies Market, by Application
7.4.6. Asia-Pacific Drug Discovery Technologies Market, by End User
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. LAMEA Drug Discovery Technologies Market, by Country
7.5.3.1. Market size and forecast
7.5.3.2. Brazil
7.5.3.2.1. Brazil Drug Discovery Technologies Market, by Technology
7.5.3.2.2. Brazil Drug Discovery Technologies Market, by Application
7.5.3.2.3. Brazil Drug Discovery Technologies Market, by End User
7.5.3.3. Saudi Arabia
7.5.3.3.1. Saudi Arabia Drug Discovery Technologies Market, by Technology
7.5.3.3.2. Saudi Arabia Drug Discovery Technologies Market, by Application
7.5.3.3.3. Saudi Arabia Drug Discovery Technologies Market, by End User
7.5.3.4. South Africa
7.5.3.4.1. South Africa Drug Discovery Technologies Market, by Technology
7.5.3.4.2. South Africa Drug Discovery Technologies Market, by Application
7.5.3.4.3. South Africa Drug Discovery Technologies Market, by End User
7.5.3.5. Rest of LAMEA
7.5.3.5.1. Rest of LAMEA Drug Discovery Technologies Market, by Technology
7.5.3.5.2. Rest of LAMEA Drug Discovery Technologies Market, by Application
7.5.3.5.3. Rest of LAMEA Drug Discovery Technologies Market, by End User
7.5.4. LAMEA Drug Discovery Technologies Market, by Technology
7.5.5. LAMEA Drug Discovery Technologies Market, by Application
7.5.6. LAMEA Drug Discovery Technologies Market, by End User

Chapter: 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. ALBANY MOLECULAR RESEARCH INC. (AMRI)
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. ARQULE, INC.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. BIO-RAD LABORATORIES, INC.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. CALIPER LIFE SCIENCES (PERKINELMER INC.)
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. CELERA CORPORATION
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. CHARLES RIVER LABORATORIES, INC.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. EVOTEC A.G.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. F. HOFFMANN-LA ROCHE AG
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. THERMO FISHER SCIENTIFIC
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World Drug Discovery Technologies Market - Opportunities and Forecasts, 2014 -2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
Connect To Analyst
 

FREQUENTLY ASKED
QUESTIONS?

 
Read More
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
Request Customization
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
report-img

Published in  Aug 2018

PEGylated Protein Therapeutics Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

Download Sample
report-img

Published in  Jul 2018

Cytogenetics Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

Download Sample
report-img

Published in  Jul 2018

Asia-Pacific IVF Services Market- Global Opportunity Analysis and Industry Forecast, 2018-2028

Download Sample
report-img

Published in  Jul 2018

Anticoagulants Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

Download Sample
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Request Sample

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo